SA
LINE logo
Lineage, Inc.(LINE)
Closing price · checked 8:30 PM ETAbout this dataData status
$31.22▼-1.18 (-3.64%)
Extended:$31.22+0.00 (+0.00%)· 8:30 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Lineage, Inc. (LINE)

Net Income Growth

-25.99%

TTM · Period ending:

LINE logo

LINE Net Income Growth

Year-over-year change vs the same period a year earlier

Latest reported-25.99%
LINE TTM Net Income YoY % (-51.81% → -25.99%)
High-resolution chart · PNG

What is net income growth?

Year-over-year net income growth rate.

Compare net income growth

Values are from the market snapshot of .

LINE net income growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters. Change compares each value with the period before it, in percentage points.

Lineage, Inc. Net Income Growth — Trailing twelve months (TTM)
Period endingNet Income GrowthChange
-25.9887%−95.92 pts
69.9288%−6.67 pts
76.6026%−8.34 pts
84.9398%+2.57 pts
82.3723%+83.07 pts
-0.6988%+25.34 pts
-26.0351%+25.77 pts
-51.8061%—

Frequently asked questions: LINE net income growth

What is Lineage, Inc. (LINE)'s current net income growth?

Lineage, Inc. (LINE)'s latest reported net income growth (TTM) is -25.99% as of Sep 30, 2026. Year-over-year net income growth rate.

How much historical net income growth data is available for LINE?

Stock Alarm Pro provides 8 dated trailing twelve months (ttm) observations for Lineage, Inc. (LINE)'s net income growth, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare LINE's net income growth to peers or set an alert?

You can compare LINE's net income growth directly against sector peers (WELL, PLD, EQIX, AMT) on Stock Alarm Pro, open the multi-ticker series in Chart Studio, or set real-time price and valuation alerts on LINE delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.